iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients
NCT03364257 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2019-03-21
Summary
Prospective, multicentre French observational study assessing the performance and medico-economic utility of iDTECT Blood versus conventional microbiologic diagnosis in patients with febrile neutropenia
Conditions
- Febrile Neutropenia
- Acute Leukemia
- Stem Cell Transplantation
- Infection
Interventions
- DIAGNOSTIC_TEST
-
iDTECT Blood
Next generation sequencing-based shot-gun metagenomic test for the diagnosis of viral or bacterial infections using blood samples
Sponsors & Collaborators
-
Pathoquest
lead INDUSTRY
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-18
- Primary Completion
- 2019-04-30
- Completion
- 2019-05-31
Countries
- France
Study Locations
More Related Trials
-
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
NCT00003805 ·Status: COMPLETED ·Phase: PHASE3
-
Shared Health Information System for Febrile Neutropenia
NCT03087227 ·Status: COMPLETED ·Phase: NA
-
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
NCT00190463 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
NCT02463747 ·Status: UNKNOWN ·Phase: PHASE4
-
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
NCT03434795 ·Status: COMPLETED
-
Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia
NCT01714570 ·Status: COMPLETED ·Phase: NA
-
Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
NCT02912117 ·Status: COMPLETED
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
Registry of Febrile Neutropenia and Invasive Fungal Infections
NCT01684189 ·Status: UNKNOWN
-
Fever and Neutropenia in Pediatric Oncology Patients
NCT03768869 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
NCT03235570 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
NCT06510868 ·Status: RECRUITING
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
NCT05793073 ·Status: COMPLETED
-
Pentaglobin in CRE and PA Neutropenic Infections
NCT03494959 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
NCT04009941 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
NCT04000711 ·Status: COMPLETED ·Phase: NA
-
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616 ·Status: COMPLETED ·Phase: PHASE2
-
CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
NCT05061654 ·Status: WITHDRAWN ·Phase: PHASE4
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED
-
Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
NCT03404752 ·Status: UNKNOWN ·Phase: PHASE3